The most accurate biomarkers currently available for AD diagnosis are retrieved in cerebrospinal fluid (CSF), where it is possible to dose amyloid beta (Aβ), tau protein, and phosphorylated tau protein [5]. This evidence concerns the gene MAPT and Alzheimer disease.